Agilent Releases New Vial Sampler Tray Capacity

Publication
Article
In the Lab eNewsletterPharmaceutical Technology's In the Lab eNewsletter, June 2023
Volume 18
Issue 6

The Agilent 8697 Headspace Sampler-XL Tray has a 120-vial capacity.

Agilent released an announcement of its Agilent 8697 Headspace Sampler -XL Tray, which features 120-vial capacity, in addition to their existing 48-vial capacity tray. In addition to the capacity increase, the new tray includes new instrument intelligence features that are designed for increased uptime and operator ease-of-use relative to its predecessor.

According to a press release from May 1, 2023, the device’s intelligence features are enabled through self-monitoring operations and guiding operators that use various troubleshooting and maintenance procedures. The system performs automated system checks, including leak checks, early maintenance feedback, and self-diagnostics. Additionally, the new tray can be run with alternate carrier gasses due to the separation of vial pressurization and the sample loop for added method flexibility.

“Labs that run headspace GC [gas chromatography] systems know that if they encounter problems during a sequence, and the vials are punctured, they may have to rerun or recollect samples,” said Mike Zhang, vice-president and general manager of Agilent’s Gas Phase Separations Division. “The 8697 and now the 8697 Headspace Sampler-XL Tray virtually eliminate that problem. The complete GC headspace system checks to ensure that the system and data quality are up to SOP [standard operating procedure] standards, avoiding recollection of samples and reruns.”

Source: Agilent

Recent Videos
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Related Content